Publication: Managed Healthcare Executive
In a presentation at the Patient-Centered Oncology Care conference, Debra Patt, M.D., PhD, MBA, executive vice president of policy and strategic initiatives at Texas Oncology, discussed the proliferation of biosimilars. Dr. Patt shared her perspective on issues affecting biosimilar uptake, including inventory, cost, and insurance decisions.
View the full story at Managed Healthcare Executive.